Recent advances in selective photothermal therapy of tumor

Photothermal therapy (PTT), which converts light energy to heat energy, has become a new research hotspot in cancer treatment. Although researchers have investigated various ways to improve the efficiency of tumor heat ablation to treat cancer, PTT may cause severe damage to normal tissue due to the...

Full description

Saved in:
Bibliographic Details
Published in:Journal of nanobiotechnology Vol. 19; no. 1; pp. 335 - 15
Main Authors: Zhao, Liping, Zhang, Xu, Wang, Xiaoxia, Guan, Xiuwen, Zhang, Weifeng, Ma, Jinlong
Format: Journal Article
Language:English
Published: London BioMed Central 24.10.2021
BioMed Central Ltd
Springer Nature B.V
BMC
Subjects:
ISSN:1477-3155, 1477-3155
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Photothermal therapy (PTT), which converts light energy to heat energy, has become a new research hotspot in cancer treatment. Although researchers have investigated various ways to improve the efficiency of tumor heat ablation to treat cancer, PTT may cause severe damage to normal tissue due to the systemic distribution of photothermal agents (PTAs) in the body and inaccurate laser exposure during treatment. To further improve the survival rate of cancer patients and reduce possible side effects on other parts of the body, it is still necessary to explore PTAs with high selectivity and precise treatment. In this review, we summarized strategies to improve the treatment selectivity of PTT, such as increasing the accumulation of PTAs at tumor sites and endowing PTAs with a self-regulating photothermal conversion function. The views and challenges of selective PTT were discussed, especially the prospects and challenges of their clinical applications.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1477-3155
1477-3155
DOI:10.1186/s12951-021-01080-3